Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model.

[1]  A. Sheoran,et al.  Passive immunization with Leptospira LPS-specific agglutinating but not non-agglutinating monoclonal antibodies protect guinea pigs from fatal pulmonary hemorrhages induced by serovar Copenhageni challenge. , 2011, Vaccine.

[2]  M. Reis,et al.  Heterologous expression of pathogen-specific genes ligA and ligB in the saprophyte Leptospira biflexa confers enhanced adhesion to cultured cells and fibronectin , 2011, BMC Microbiology.

[3]  B. Adler,et al.  Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. , 2011, Vaccine.

[4]  D. Hoke,et al.  Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. , 2011, The Journal of infectious diseases.

[5]  S. McDonough,et al.  Leptospira immunoglobulin‐like protein B (LigB) binding to the C‐terminal fibrinogen αC domain inhibits fibrin clot formation, platelet adhesion and aggregation , 2011, Molecular microbiology.

[6]  R. Raman,et al.  Big Domains Are Novel Ca2+-Binding Modules: Evidences from Big Domains of Leptospira Immunoglobulin-Like (Lig) Proteins , 2010, PloS one.

[7]  L. Nicholson,et al.  A novel fibronectin type III module binding motif identified on C-terminus of Leptospira immunoglobulin-like protein, LigB. , 2009, Biochemical and biophysical research communications.

[8]  Yung-Fu Chang,et al.  Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model. , 2009, Vaccine.

[9]  Yung-Fu Chang,et al.  Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis. , 2009, Vaccine.

[10]  S. Normark,et al.  Bacterial adhesins in host-microbe interactions. , 2009, Cell host & microbe.

[11]  L. Nicholson,et al.  Repeated Domains of Leptospira Immunoglobulin-like Proteins Interact with Elastin and Tropoelastin* , 2009, The Journal of Biological Chemistry.

[12]  T. Beddoe,et al.  Crystal structure of LipL32, the most abundant surface protein of pathogenic Leptospira spp. , 2009, Journal of molecular biology.

[13]  Yung-Fu Chang,et al.  Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. , 2009, Microbes and infection.

[14]  Yung-Fu Chang,et al.  Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. , 2009, Vaccine.

[15]  A. Ko,et al.  Major Surface Protein LipL32 Is Not Required for Either Acute or Chronic Infection with Leptospira interrogans , 2008, Infection and Immunity.

[16]  M. Daha,et al.  Immune Evasion of Leptospira Species by Acquisition of Human Complement Regulator C4BP , 2008, Infection and Immunity.

[17]  M. Reis,et al.  Targeted Mutagenesis in Pathogenic Leptospira Species: Disruption of the LigB Gene Does Not Affect Virulence in Animal Models of Leptospirosis , 2008, Infection and Immunity.

[18]  R. Raman,et al.  Calcium Binds to Leptospiral Immunoglobulin-like Protein, LigB, and Modulates Fibronectin Binding* , 2008, Journal of Biological Chemistry.

[19]  Yung-Fu Chang,et al.  The C-terminal variable domain of LigB from Leptospira mediates binding to fibronectin , 2008, Journal of veterinary science.

[20]  P. Ho,et al.  In LipL32, the Major Leptospiral Lipoprotein, the C Terminus Is the Primary Immunogenic Domain and Mediates Interaction with Collagen IV and Plasma Fibronectin , 2008, Infection and Immunity.

[21]  Yung-Fu Chang,et al.  Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. , 2008, Vaccine.

[22]  G. Cerqueira,et al.  Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. , 2007, Vaccine.

[23]  R. Hodges,et al.  Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa. , 2007, Journal of molecular biology.

[24]  Hongxuan He,et al.  Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. , 2007, Vaccine.

[25]  M. Reis,et al.  The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. , 2007, Vaccine.

[26]  Melissa M. Kelley,et al.  Physiological Osmotic Induction of Leptospira interrogans Adhesion: LigA and LigB Bind Extracellular Matrix Proteins and Fibrinogen , 2007, Infection and Immunity.

[27]  D. Haake.  Hamster Model of Leptospirosis , 2006, Current protocols in microbiology.

[28]  Yung-Fu Chang,et al.  Immunoprotection of Recombinant Leptospiral Immunoglobulin-Like Protein A against Leptospira interrogans Serovar Pomona Infection , 2006, Infection and Immunity.

[29]  T. Meri,et al.  Regulation of complement activation at the C3-level by serum resistant leptospires. , 2005, Microbial pathogenesis.

[30]  B. Nowicki,et al.  Vaccination with Purified Dr Fimbriae Reduces Mortality Associated with Chronic Urinary Tract Infection Due to Escherichia coli Bearing Dr Adhesin , 2005, Infection and Immunity.

[31]  B. Roe,et al.  Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA. , 2004, Journal of medical microbiology.

[32]  B. Blanchet,et al.  Étude de l'efficacité du vaccin Spirolept®contre la leptospirose par la protection passive de rongeurs de laboratoire , 2004 .

[33]  S. Normark,et al.  Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice. , 2004, Vaccine.

[34]  Haruo Watanabe,et al.  Leptospiral immunoglobulin-like proteins elicit protective immunity. , 2004, Vaccine.

[35]  M. Willig,et al.  Leptospirosis: a zoonotic disease of global importance. , 2003, The Lancet. Infectious diseases.

[36]  C. Branger,et al.  Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis , 2003, Veterinary Record.

[37]  J. Timoney,et al.  Cloning and Molecular Characterization of an Immunogenic LigA Protein of Leptospira interrogans , 2002, Infection and Immunity.

[38]  B. Adler,et al.  Leptospira and Leptospirosis , 2001, Current Topics in Microbiology and Immunology.

[39]  R Möllby,et al.  Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. , 2000, The Journal of infectious diseases.

[40]  E. Wagar,et al.  Leptospiral Outer Membrane Proteins OmpL1 and LipL41 Exhibit Synergistic Immunoprotection , 1999, Infection and Immunity.

[41]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[42]  Burnette Wn.  Recombinant subunit vaccines. , 1991 .

[43]  M. Petruccelli,et al.  Detection of an antigenic protein of Leptospira interrogans which shares epitopes with the equine cornea and lens. , 1997, Veterinary journal.

[44]  Gérard Ozanne,et al.  Estimation of endopoints in biological systems , 1984 .